...
首页> 外文期刊>Medical care >The Impact of a National Health Information Exchange Program Under a Single-payer System
【24h】

The Impact of a National Health Information Exchange Program Under a Single-payer System

机译:国家卫生信息交流计划在单笔付款系统下的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: This study aimed to evaluate the impact of the PharmaCloud program, a health information exchange program implemented in 2013, on medication duplication under a single-payer, universal health insurance program in Taiwan. Study Design: This study employed a retrospective pre-post study design and used nationwide health insurance claim data from 2013 to 2015. A difference-in-difference analysis was conducted to evaluate the effects of inquiry rate on the probability of receiving duplicate medications and on the number of days of overlapping medication prescriptions after implementation of the PharmaCloud program. Results: The study subjects included patients receiving medications in 7 categories: antihypertension drugs, 217,200; antihyperlipidemic drugs, 69,086; hypoglycemic agents, 103,962; antipsychotic drugs, 15,479; antidepressant drugs, 12,057; sedative and hypnotic drugs, 56,048; and antigout drugs, 18,250. Up to 2015, the overall PharmaCloud inquiry rate has increased to 55.36%-69.16%. Compared with subjects in 2013, subjects in 2014 and 2015 had a significantly lower likelihood of receiving duplicate medication in all 7 medication groups; for instance, for antihypertension drug users, the odds ratio (OR) was 0.91 with 95% confidence interval (CI)=0.90-0.92 in 2014, and the OR was 0.81 with 95% confidence interval=0.81-0.82 in 2015. However, a higher inquiry rate led to a lower likelihood of receiving duplicate medication and shorter periods of overlapping medications only in some of the medication groups. Conclusions: The health information exchange program has reduced medication duplication, yet the reduction was not entirely associated with record inquiries. The hospitals have responded to the challenge of medication duplication by enhancing internal prescription control via a prescription alert system, which may have contributed to the reduction in duplicate medications and is a positive, unintended consequence of the intervention.
机译:目的:本研究旨在评估Pharmacloud计划的影响,这是2013年实施的健康信息交换计划,在台湾的单一付款人员,普遍健康保险计划下的药物重复。研究设计:本研究采用了回顾性的研究前的研究设计,并从2013年到2015年使用了全国健康保险索赔数据。进行了差异差分分析,以评估调查率对接受重复药物的概率的影响。在实施PharmacCloud程序后重叠药物处方的天数。结果:该研究受试者包括在7个类别中接受药物的患者:抗高血压药物,217,200;抗高兴血性药物,69,086;降血糖剂,​​103,962;抗精神病药物,15,479;抗抑郁药物,12,057;镇静和催眠药,56,048;和抗原药物,18,250。截至2015年,全面药房询价率增加到55.36%-69.16%。与2013年的主题相比,2014年和2015年的主题在所有7种药物组中接受重复药物的可能性显着降低;例如,对于抗高血压药物使用者,2014年,差异为0.91,95%置信区间(CI)= 0.90-0.92,且为0.81,2015年95%置信区间= 0.81-0.82。然而,较高的查询率导致仅在一些药物组中接受重复药物和重叠药物的较短时期的较低可能性。结论:卫生信息交换计划减少了药物复制,但减少并非完全与记录查询相关联。医院通过通过处方警报系统提高内部处方控制,对药物复制的挑战作出反应,这可能导致重复药物的减少,并且是干预的积极意外的后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号